SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-460842
Filing Date
2012-11-08
Accepted
2012-11-08 17:25:43
Documents
12
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d399025d10q.htm 10-Q 1204816
2 EX-4.8 d399025dex48.htm EX-4.8 16985
3 EX-31.1 d399025dex311.htm EX-31.1 6337
4 EX-31.2 d399025dex312.htm EX-31.2 6546
5 EX-32.1 d399025dex321.htm EX-32.1 3283
6 EX-32.2 d399025dex322.htm EX-32.2 4125
  Complete submission text file 0001193125-12-460842.txt   8695287

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT isco-20120930.xml EX-101.INS 1185690
8 XBRL TAXONOMY EXTENSION SCHEMA isco-20120930.xsd EX-101.SCH 71180
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE isco-20120930_cal.xml EX-101.CAL 63870
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE isco-20120930_def.xml EX-101.DEF 289473
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE isco-20120930_lab.xml EX-101.LAB 560199
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE isco-20120930_pre.xml EX-101.PRE 389933
Mailing Address 2595 JASON COURT OCEANSIDE CA 92056
Business Address 2595 JASON COURT OCEANSIDE CA 92056 760-940-6383
International Stem Cell CORP (Filer) CIK: 0001355790 (see all company filings)

IRS No.: 204494098 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51891 | Film No.: 121191041
SIC: 2834 Pharmaceutical Preparations